Related Experiment Videos
Coagulation studies in infants of diabetic mothers
American Journal of Diseases of Children (1960)
|August 1, 1979
Insights
Infants born to diabetic mothers show no significant coagulation changes. Lower platelet counts were observed, but this does not explain the increased risk of blood clots in these infants.
Area of Science:
- Neonatal Medicine
- Hematology
- Endocrinology
Background:
- Infants of diabetic mothers (IDMs) are at increased risk for thrombotic events.
- The underlying mechanisms for this thrombotic tendency are not fully understood.
- Hemostasis alterations are a potential contributing factor.
Purpose of the Study:
- To investigate coagulation profiles in infants of diabetic mothers.
- To determine if altered hemostasis contributes to the thrombotic risk in IDMs.
Main Methods:
- Coagulation studies were performed on 17 infants of diabetic mothers.
- A control group of 11 healthy infants was included for comparison.
- Platelet counts and other hemostatic parameters were analyzed.
Main Results:
- Minor differences in coagulation parameters were observed between the groups.
- Infants of diabetic mothers exhibited lower platelet counts compared to controls.
- No significant alterations in other key hemostasis markers were detected.
Conclusions:
- The observed minor hemostatic differences, including lower platelet counts, do not fully account for the heightened thrombotic risk in infants of diabetic mothers.
- Altered hemostasis is unlikely to be the primary driver of increased thrombosis in this population.
- Further research is needed to elucidate the specific causes of thrombotic events in IDMs.
Abstract:
Coagulation studies on 17 infants of diabetic mothers were compared with 11 control infants. Only minor differences were noted, including lower platelet counts in the former group. On the basis of these findings, the increased thrombotic tendency in diabetic progeny cannot be attributed to altered hemostasis.